1-3 of 3
Michael (Luhua) Wang, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Results from a Phase 2 Extension Study of Patients with Multiple Myeloma or Solid Tumors Previously Enrolled in Carfilzomib Company-Sponsored Phase 1 and 2 Clinical Trials (PX-171-010)

David S. Siegel, MD PhD, Jesus G. Berdeja, MD, Jeffrey R. Infante, MD, Jonathan L. Kaufman, MD, Michael (Luhua) Wang, MD, Thomas G. Martin, MD, Ruben Niesvizky, MD, Frederic J. Reu, MD, Sundar Jagannath, MD, Kanya Rajangam, MDPhD, Mei Huang, MS, Ravi Vij, MD
Journal: Blood
Blood (2014) 124 (21): 2134.
https://doi.org/10.1182/blood.V124.21.2134.2134
Published: 2014
Journal Articles

Initial Results of a Phase 1/2a, Dose Escalation Study of PVX-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Michael (Luhua) Wang, MD, Ajay K. Nooka, MD MPH, Andrew J. Yee, MD, Sheeba K. Thomas, MD, Elizabeth O'Donnell, MD, Jatin Shah, MD, Donna M. Weber, MD, Jonathan L. Kaufman, MD, Sagar Lonial, MD, David Avigan, MD, Noopur Raje, MD
Journal: Blood
Blood (2014) 124 (21): 4737.
https://doi.org/10.1182/blood.V124.21.4737.4737
Published: 2014
Journal Articles

Ibrutinib and Rituximab Are an Efficacious and Safe Combination in Relapsed Mantle Cell Lymphoma: Preliminary Results from a Phase II Clinical Trial

Michael (Luhua) Wang, MD, Fredrick Hagemeister, MD, Jason R. Westin, MD, Luis Fayad, MD, Felipe Samaniego, MD, Francesco Turturro, MD, Wendy Chen, Liang Zhang, MD PhD, Maria Badillo, BS, Maria DeLa Rosa, Alicia Addison, Larry W. Kwak, MD PhD, Jorge E. Romaguera, MD
Journal: Blood
Blood (2014) 124 (21): 627.
https://doi.org/10.1182/blood.V124.21.627.627
Published: 2014